Cargando…
Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice
Serum lipid levels are closely related to the structure and function of blood vessels. Chronic hyperlipidemia may lead to damage in both the cardio- and the cerebrovascular systems. Vascular dysfunctions, including impairments of the blood-brain barrier, are known to be associated with neurodegenera...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403644/ https://www.ncbi.nlm.nih.gov/pubmed/32067608 http://dx.doi.org/10.2174/1381612826666200218101818 |
_version_ | 1783566982897991680 |
---|---|
author | Tóth, Melinda E. Dukay, Brigitta Hoyk, Zsófia Sántha, Miklós |
author_facet | Tóth, Melinda E. Dukay, Brigitta Hoyk, Zsófia Sántha, Miklós |
author_sort | Tóth, Melinda E. |
collection | PubMed |
description | Serum lipid levels are closely related to the structure and function of blood vessels. Chronic hyperlipidemia may lead to damage in both the cardio- and the cerebrovascular systems. Vascular dysfunctions, including impairments of the blood-brain barrier, are known to be associated with neurodegenerative diseases. A growing number of evidence suggests that cardiovascular risk factors, such as hyperlipidemia, may increase the likelihood of developing dementia. Due to differences in lipoprotein metabolism, wild-type mice are protected against diet-induced hypercholesterolemia, and their serum lipid profile is different from that observed in humans. Therefore, several transgenic mouse models have been established to study the role of different apolipoproteins and their receptors in lipid metabolism, as well as the complications related to pathological lipoprotein levels. This mini-review focused on a transgenic mouse model overexpressing an apolipoprotein, the human ApoB-100. We discussed literature data and current advancements on the understanding of ApoB-100 induced cardio- and cerebrovascular lesions in order to demonstrate the involvement of this type of apolipoprotein in a wide range of pathologies, and a link between hyperlipidemia and neurodegeneration. |
format | Online Article Text |
id | pubmed-7403644 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-74036442020-08-17 Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice Tóth, Melinda E. Dukay, Brigitta Hoyk, Zsófia Sántha, Miklós Curr Pharm Des Article Serum lipid levels are closely related to the structure and function of blood vessels. Chronic hyperlipidemia may lead to damage in both the cardio- and the cerebrovascular systems. Vascular dysfunctions, including impairments of the blood-brain barrier, are known to be associated with neurodegenerative diseases. A growing number of evidence suggests that cardiovascular risk factors, such as hyperlipidemia, may increase the likelihood of developing dementia. Due to differences in lipoprotein metabolism, wild-type mice are protected against diet-induced hypercholesterolemia, and their serum lipid profile is different from that observed in humans. Therefore, several transgenic mouse models have been established to study the role of different apolipoproteins and their receptors in lipid metabolism, as well as the complications related to pathological lipoprotein levels. This mini-review focused on a transgenic mouse model overexpressing an apolipoprotein, the human ApoB-100. We discussed literature data and current advancements on the understanding of ApoB-100 induced cardio- and cerebrovascular lesions in order to demonstrate the involvement of this type of apolipoprotein in a wide range of pathologies, and a link between hyperlipidemia and neurodegeneration. Bentham Science Publishers 2020-04 2020-04 /pmc/articles/PMC7403644/ /pubmed/32067608 http://dx.doi.org/10.2174/1381612826666200218101818 Text en © 2020 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Tóth, Melinda E. Dukay, Brigitta Hoyk, Zsófia Sántha, Miklós Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice |
title | Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice |
title_full | Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice |
title_fullStr | Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice |
title_full_unstemmed | Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice |
title_short | Cerebrovascular Changes and Neurodegeneration Related to Hyperlipidemia: Characteristics of the Human ApoB-100 Transgenic Mice |
title_sort | cerebrovascular changes and neurodegeneration related to hyperlipidemia: characteristics of the human apob-100 transgenic mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403644/ https://www.ncbi.nlm.nih.gov/pubmed/32067608 http://dx.doi.org/10.2174/1381612826666200218101818 |
work_keys_str_mv | AT tothmelindae cerebrovascularchangesandneurodegenerationrelatedtohyperlipidemiacharacteristicsofthehumanapob100transgenicmice AT dukaybrigitta cerebrovascularchangesandneurodegenerationrelatedtohyperlipidemiacharacteristicsofthehumanapob100transgenicmice AT hoykzsofia cerebrovascularchangesandneurodegenerationrelatedtohyperlipidemiacharacteristicsofthehumanapob100transgenicmice AT santhamiklos cerebrovascularchangesandneurodegenerationrelatedtohyperlipidemiacharacteristicsofthehumanapob100transgenicmice |